Protalix BioTherapeutics Inc Stock Forecast
Volatile ride for Protalix BioTherapeutics Inc stock price on Friday moving between $1.09 and $1.22
(Updated on Apr 26, 2024)
The Protalix BioTherapeutics Inc stock price fell by -2.54% on the last day (Friday, 26th Apr 2024) from $1.18 to $1.15. During the last trading day the stock fluctuated 11.93% from a day low at $1.09 to a day high of $1.22. The price has risen in 5 of the last 10 days but is still down by -2.54% for this period. Volume has increased on the last day by 775 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 954 thousand shares were bought and sold for approximately $1.10 million.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -23.40% during the next 3 months and, with a 90% probability hold a price between $0.83 and $1.04 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PLX Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 1.77%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Protalix BioTherapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.17 and $1.26. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Protalix BioTherapeutics Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Protalix BioTherapeutics Inc stock
Protalix BioTherapeutics Inc finds support from accumulated volume at $1.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.130 between high and low, or 11.93%. For the last week, the stock has had daily average volatility of 6.81%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (PLX) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Protalix BioTherapeutics Inc to open at $1.15, and during the day (based on 14 day Average True Range), to move between $1.08 and $1.22, which gives a possible trading interval of +/-$0.0708 (+/-6.16%) up or down from last closing price. If Protalix BioTherapeutics Inc takes out the full calculated possible swing range there will be an estimated 12.31% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.14 (0.87%) than the resistance at $1.22 (6.09%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Protalix BioTherapeutics Inc will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.0200. We will update the financials statements for Protalix BioTherapeutics Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.63% in the first trading day after earnings release.
Is Protalix BioTherapeutics Inc stock A Buy?
Protalix BioTherapeutics Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -3.900 Sell Candidate Unchanged
Predicted Opening Price for Protalix BioTherapeutics Inc of Monday, April 29, 2024
Fair opening price April 29, 2024 | Current price |
---|---|
$1.15 ( 0.290%) | $1.15 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PLX
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.28 | 11.59 % | |
R2 | 1.23 | 7.28 % | ||
R1 | 1.20 | 4.61 % | ||
Current price: | 1.15 | |||
Support | S1 | 1.10 | -4.03 % | |
S2 | 1.07 | -6.70 % | ||
S3 | 1.02 | -11.01 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.37 | 19.13 % | |
R2 | 1.30 | 13.04 % | ||
R1 | 1.22 | 6.09 % | ||
Current price | 1.15 | |||
Support | S1 | 1.14 | -0.87% | |
S2 | 1.13 | -1.74% | ||
S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Protalix BioTherapeutics Inc Stock.